Skip to content
10-Q

Quarterly Report

IMMUNE PHARMACEUTICALS INC

0001144204-18-059964

← back to feed
Filed
Nov 14, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2018 · Nov 5, 2018 49.31M sh
Capex Q3 2018 · Sep 30, 2018 $99K
Capex Q3 2018 · Sep 30, 2017 $22K
Operating Cash Flow Q3 2018 · Sep 30, 2018 −$8.34M
Operating Cash Flow Q3 2018 · Sep 30, 2017 −$5.22M
Long Term Debt Q3 2018 · Sep 30, 2018 $870K
Long Term Debt Q3 2018 · Dec 31, 2017 $1.46M
Cash And Equivalents Q3 2018 · Sep 30, 2018 $76K
Cash And Equivalents Q3 2018 · Dec 31, 2017 $6.78M
Cash And Equivalents Q3 2018 · Sep 30, 2017 $76K
Cash And Equivalents Q3 2018 · Dec 31, 2016 $271K
Stockholders Equity Q3 2018 · Sep 30, 2018 $842K
Stockholders Equity Q3 2018 · Dec 31, 2017 $13.76M
Current Liabilities Q3 2018 · Sep 30, 2018 $14.86M
Current Liabilities Q3 2018 · Dec 31, 2017 $9.25M
Total Liabilities Q3 2018 · Sep 30, 2018 $19.87M
Total Liabilities Q3 2018 · Dec 31, 2017 $14.85M
Current Assets Q3 2018 · Sep 30, 2018 $364K
Current Assets Q3 2018 · Dec 31, 2017 $7.03M
Total Assets Q3 2018 · Sep 30, 2018 $20.72M
Total Assets Q3 2018 · Dec 31, 2017 $28.61M
Sga Expense Q3 2018 · Sep 30, 2018 $1.64M
Sga Expense Q3 2018 · Sep 30, 2018 $4.7M
Sga Expense Q3 2018 · Sep 30, 2017 $1.61M
Sga Expense Q3 2018 · Sep 30, 2017 $4.64M
Rd Expense Q3 2018 · Sep 30, 2018 $2.05M
Rd Expense Q3 2018 · Sep 30, 2018 $6.16M
Rd Expense Q3 2018 · Sep 30, 2017 $1.23M
Rd Expense Q3 2018 · Sep 30, 2017 $3.67M
Net Income Q3 2018 · Sep 30, 2018 −$4.13M
Net Income Q3 2018 · Sep 30, 2018 −$13.23M
Net Income Q3 2018 · Sep 30, 2017 −$6.05M
Net Income Q3 2018 · Sep 30, 2017 −$14.74M
Operating Income Q3 2018 · Sep 30, 2018 −$3.7M
Operating Income Q3 2018 · Sep 30, 2018 −$10.87M
Operating Income Q3 2018 · Sep 30, 2017 −$2.84M
Operating Income Q3 2018 · Sep 30, 2017 −$8.32M
Revenue Q3 2018 · Sep 30, 2018 $0
Revenue Q3 2018 · Sep 30, 2018 $0
Revenue Q3 2018 · Sep 30, 2017 $0
Revenue Q3 2018 · Sep 30, 2017 $0